Synthesis of chalcone analogues with increased antileishmanial activity
- 1 March 2006
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 14 (5), 1538-1545
- https://doi.org/10.1016/j.bmc.2005.10.005
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Miltefosine for New World Cutaneous LeishmaniasisClinical Infectious Diseases, 2004
- Oral Delivery of Meglumine Antimoniate-β-Cyclodextrin Complex for Treatment of LeishmaniasisAntimicrobial Agents and Chemotherapy, 2004
- Leishmaniasis– current chemotherapy and recent advances in the search for novel drugsTrends in Parasitology, 2003
- Antileishmanial activities of dihydrochalcones from piper elongatum and synthetic related compounds. Structural requirements for activityBioorganic & Medicinal Chemistry, 2003
- Trypanocidal and Leishmanicidal Properties of Substitution-Containing ChalconesAntimicrobial Agents and Chemotherapy, 2003
- Chalcones from Chinese liquorice inhibit proliferation of T cells and production of cytokinesInternational Immunopharmacology, 2002
- Inhibition of Fumarate Reductase in Leishmania major and L. donovani by ChalconesAntimicrobial Agents and Chemotherapy, 2001
- Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activitiesLife Sciences, 2001
- Synthesis of xanthoxyline derivatives with antinociceptive and antioedematogenic activitiesEuropean Journal of Medicinal Chemistry, 1996
- Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovaniAntimicrobial Agents and Chemotherapy, 1994